1. Affiliations
In the original publication [1], there was an error with the affiliation (1). The P.O. box number has been added.
2. Figure/Table Legend
In the original publication [1], there was a mistake with Figures 3 and 6. For Figure 3, the yellow highlight boxes have been removed and for Figure 6, GCLC has been replaced with GCLM and SLC3A2 with SLC7A11. The figures appear below.
Figure 3.
Overall view of the transcriptomic and metabolomic profiles of HT-29 cells after treatment with PRO and/or CAP compared with untreated cells. (A) Heatmap showing the expression pattern of genes in HT-29-treated groups versus the control group. (B) Volcano plot showing the positions of differentially upregulated and downregulated genes in the PRO, CAP, and PRO + CAP groups versus the control group. (C) Total ion chromatograms of the extracted metabolites from treated and untreated HT-29 cells, which were run in LTQ-XL linear ion trap LC-MS. (D) Principal component analysis (PCA) of comprehensive metabolites from treated and untreated HT-29 cells. (E) Correlation heatmaps of treated and untreated HT-29 cells. (F) Heatmaps of differentially expressed metabolites in treated and untreated HT-29 cells. (G) The top twenty-five pathways enriched in the metabolome analysis of treated and untreated HT-29 cell lines.
Figure 6.
Proposed mechanism of combined therapy in HT-29 cell line based on RNA-seq results. The figure was created with BioRender (www.biorender.com).
3. Supplementary Files
In the original supplementary files, there was a typo for the reference list used in Table S4. The name of the reference list has been changed from “References of Table S6” to “References of Table S4”.
The scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Reference
- Alzahrani, S.M.; Al Doghaither, H.A.; Alkhatabi, H.A.; Basabrain, M.A.; Pushparaj, P.N. Propranolol and Capecitabine Synergy on Inducing Ferroptosis in Human Colorectal Cancer Cells: Potential Implications in Cancer Therapy. Cancers 2025, 17, 1470. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).